Bernard D. Johnson
Illinois Department of Public Health(US)Pearl River Community College(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Synthesis and Characterization of Heterocyclic Compounds, Quinazolinone synthesis and applications, Synthesis and biological activity, Click Chemistry and Applications
Most-Cited Works
- → Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase(2004)630 cited
- → Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity(2005)295 cited
- → 6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity(2001)272 cited
- → Synthesis and Structure−Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2)(2002)263 cited
- → Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man(2009)240 cited
- → 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of Epidermal Growth Factor Receptor Kinase and Their Bioisosteric Relationship to the 4-Anilino-6,7-dialkoxyquinazoline Inhibitors